Document Detail


Engineered embryonic endothelial progenitor cells as therapeutic Trojan horses.
MedLine Citation:
PMID:  15144946     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
While the hematogenic contribution of circulating endothelial cells to tumor angiogenesis is not entirely understood, one can exploit this phenomenon as a therapeutic strategy. In this issue of Cancer Cell, show that murine embryonic endothelial progenitor cells preferentially home to sites of lung metastases, evade immunological rejection, and can exert a bystander antitumor effect when modified to contain a suicide gene construct that activates a prodrug. Treatment with the prodrug led to improved survival in syngeneic and nonsyngeneic tumor-bearing mouse models. The conceptual advance put forward by this study might result in translational applications.
Authors:
Wadih Arap; Renata Pasqualini
Related Documents :
18243696 - A cell-penetrating peptidic grp78 ligand for tumor cell-specific prodrug therapy.
19565926 - Tumor-targeted salmonella typhimurium overexpressing cytosine deaminase: a novel, tumor...
7889476 - Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus ...
22729036 - High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma ...
7549756 - High prevalence of expression of p53 oncoprotein in oral carcinomas from india associat...
17482226 - (anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, mcf-7 ...
Publication Detail:
Type:  Comment; Editorial    
Journal Detail:
Title:  Cancer cell     Volume:  5     ISSN:  1535-6108     ISO Abbreviation:  Cancer Cell     Publication Date:  2004 May 
Date Detail:
Created Date:  2004-05-17     Completed Date:  2004-06-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130617     Medline TA:  Cancer Cell     Country:  United States    
Other Details:
Languages:  eng     Pagination:  406-8     Citation Subset:  IM    
Affiliation:
The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anoxia
Endothelium, Vascular / embryology*
Gene Targeting
Gene Therapy*
Genes, Transgenic, Suicide*
Genetic Engineering
Lung Neoplasms / secondary,  therapy*
Mice
Neovascularization, Pathologic / prevention & control
Prodrugs / metabolism
Stem Cells / physiology*
Chemical
Reg. No./Substance:
0/Prodrugs
Comments/Corrections
Comment On:
Cancer Cell. 2004 May;5(5):477-88   [PMID:  15144955 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intratumoral hypoxia, radiation resistance, and HIF-1.
Next Document:  Cysteine cathepsins (proteases)--on the main stage of cancer?